Efficacy of Lanreotide versus Follow-Up in Early-Stage Duodeno-Pancreatic Neuroendocrine Tumors (NETs) Related to Multiple Endocrine Neoplasia Type 1 (MEN1): Preliminary Data

被引:0
|
作者
Ramundo, V [1 ]
Marciello, F. [1 ]
Modica, R. [1 ]
Marotta, V [1 ]
Pizza, G. [1 ]
Camera, L. [1 ]
Napolitano, V [2 ]
De Luca, L. [3 ]
Colao, A. [1 ]
Faggiano, A. [1 ]
机构
[1] Univ Naples Federico II, Naples, Italy
[2] Univ Naples 2, Naples, Italy
[3] Pellegrini Hosp, Naples, Italy
关键词
multiple endocrine neoplasia type 1; lanreotide; duodeno-pancreatic nets;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
K8
引用
收藏
页码:125 / 125
页数:1
相关论文
共 47 条
  • [21] The Role of Magnetic Resonance Imaging and Endoscopic Ultrasound Imaging in the Diagnosis and Management of Pancreatic Neuroendocrine Tumors (pNET) in Patients with Multiple Endocrine Neoplasia Type 1 (MEN1)
    Tsoli, M.
    Alexandraki, K.
    Angelousi, A.
    Karoumpalis, I
    Kolomodi, D.
    Kaltsatou, M.
    Chrysochoou, M.
    Moschouris, P.
    Nikolopoulos, G.
    Mavroeidi, V
    Christakou, C.
    Kaltsas, G.
    NEUROENDOCRINOLOGY, 2018, 106 : 183 - 183
  • [22] Distinct Prognostic Factors in Sporadic and Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors
    Kfir, Sapir Kon
    Halperin, Reut
    Percik, Ruth
    Uri, Inbal
    Halpern, Naama
    Shlomai, Gadi
    Laish, Ido
    Tirosh, Amir
    Tirosh, Amit
    HORMONE AND METABOLIC RESEARCH, 2021, 53 (05) : 319 - 325
  • [23] Electron Microscopy of Pancreatic Beta Cell Neuroendocrine Tumors (NETs) in Multiple Endocrine Neoplasia Type 1 (MEN1) Knockout Mice Reveal an Adenomatous Phenotype with Depletion of Insulin Granules and Increased Mitochondrial Content
    Walls, G., V
    Clark, A.
    Thakker, R.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 230 - 230
  • [24] Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model DISCUSSION
    Vriens, Menno
    Quinn, Thomas
    Evans, Douglas
    Libutti, Steven
    Parangi, Sareh
    SURGERY, 2012, 152 (06) : 1076 - 1077
  • [25] Prognosis after surgery for multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: Functionality matters
    van Beek, Dirk-Jan
    Nell, Sjoerd
    Verkooijen, Helena M.
    Rinkes, Inne H. M. Borel
    Valk, Gerlof D.
    Vriens, Menno R.
    SURGERY, 2021, 169 (04) : 963 - 973
  • [26] Proliferation of Pancreatic Islet and Anterior Pituitary Neuroendocrine Tumours (NETs) Developing in a Mouse Model of Multiple Endocrine Neoplasia Type 1 (MEN1) Is Consistent with a Third Order Regression Mathematical Model.
    Walls, G. V.
    Jeyabalan, J.
    Reed, A. A. C.
    Hill, N. R.
    Harding, B.
    Thakker, R. V.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [27] Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus Statement
    Niederle, Bruno
    Selberherr, Andreas
    Bartsch, Detlef K.
    Brandi, Maria L.
    Doherty, Gerard M.
    Falconi, Massimo
    Goudet, Pierre
    Halfdanarson, Thorvardur R.
    Ito, Tetsuhide
    Jensen, Robert T.
    Larghi, Alberto
    Lee, Lingaku
    Oberg, Kjell
    Pavel, Marianne
    Perren, Aurel
    Sadowski, Samira M.
    Tonelli, Francesco
    Triponez, Frederic
    Valk, Gerlof D.
    O'Toole, Dermot
    Scott-Coombes, David
    Thakker, Rajesh V.
    Thompson, Geoffrey B.
    Treglia, Giorgio
    Wiedenmann, Bertram
    NEUROENDOCRINOLOGY, 2021, 111 (07) : 609 - 630
  • [28] Clinical manifestation of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in patients with multiple endocrine neoplasia type 1 (MEN-1): case series in NTUH
    Tsai, C. L.
    Cheng, T. Y.
    Tseng, Z. M.
    Chen, P. L.
    Shi, X. R.
    Wang, H. P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 245 - 245
  • [29] Causes of Death and Prognostic Factors in Multiple Endocrine Neoplasia Type 1: A Prospective Study Comparison of 106 MEN1/Zollinger-Ellison Syndrome Patients With 1613 Literature MEN1 Patients With or Without Pancreatic Endocrine Tumors
    Ito, Tetsuhide
    Igarashi, Hisato
    Uehara, Hirotsugu
    Berna, Marc J.
    Jensen, Robert T.
    MEDICINE, 2013, 92 (03) : 135 - 181
  • [30] EFFICACY OF CINACALCET THERAPY IN PATIENTS AFFECTED BY PRIMARY HYPERPARATHYROIDISM ASSOCIATED TO MULTIPLE ENDOCRINE NEOPLASIA SYNDROME TYPE 1 (MEN1): PRELIMINARY RESULTS OF THE FLORENTINE STUDY
    Giusti, Francesca
    Falchetti, Alberto
    Masi, Laura
    Cavalli, Lordana
    Fossi, Caterina
    Brandi, Maria Luisa
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 293 - 293